#

Pharmaceutical Companies

: 104
Where to invest $10,000 right now: the renaissance of real manufacturing
Review·
Where to invest $10,000 right now: the renaissance of real manufacturing
AstraZenecas drug has produced positive results in the fight against breast cancer. What about the stock?
News·
AstraZeneca's drug has produced positive results in the fight against breast cancer. What about the stock?
Trump has promised to cut the price of Ozempic to $150. Novo Nordisk and Eli Lilly shares fell
News·
Trump has promised to cut the price of Ozempic to $150. Novo Nordisk and Eli Lilly shares fell
Liver drugmaker Akero to be acquired by Novo Nordisk; shares soar 17%
News·
+1
·
Liver drugmaker Akero to be acquired by Novo Nordisk; shares soar 17%
Biotech stocks have revived after five years of stagnation. Why is growth far from complete?
News·
Biotech stocks have revived after five years of stagnation. Why is growth far from complete?
Morning in New York: focus on the aftermath of the U.S. government shutdown
News·
Morning in New York: focus on the aftermath of the U.S. government shutdown
Pfizer struck a price deal with the White House. Shares soared 6%
News·
Pfizer struck a price deal with the White House. Shares soared 6%
Morgan Stanley gave one of the worst forecasts for Novo. What could bring down the stock?
News·
Morgan Stanley gave one of the worst forecasts for Novo. What could bring down the stock?
Silicon Valley tycoons are betting on rejuvenation. Is it possible to make money on it?
Review·
Silicon Valley tycoons are betting on rejuvenation. Is it possible to make money on it?
Ilya Yasny: It is easy to lose a lot of money on investments in biotech companies
Review·
Ilya Yasny: "It is easy to lose a lot of money on investments in biotech companies"
Novo drug outperformed its Eli Lilly counterpart in trials. Time to buy stock?
News·
Novo drug outperformed its Eli Lilly counterpart in trials. Time to buy stock?
Small caps that can challenge Novo Nordisk and Eli Lilly in the obesity drug market
Small Caps·
Small caps that can challenge Novo Nordisk and Eli Lilly in the obesity drug market
Load more